dpp 4 inhibitor glp 1 agonist Target Trial of Glucagon-Like Peptide-1 Agonists versus Dipeptidyl Peptidase -4 Inhibitors and Mortality in Hemodialysis It's the first in a

GLP- 1 receptor agonists are extremely effective in controlling blood glucose levels because they increase insulin secretion, improve insulin sensitivity, and reduce glucose production in the liver

Benefits attributed to sustained IGF-1 levels maintaining muscle protein synthesis rates throughout the day

Moderating the rate of weight loss can significantly reduce the risk of telogen effluvium

The aforementioned research by Hefferman et al has also indicated that Frag 176-191 may substantially support fatty acid oxidation rates, particularly noted in models of obesity, where fat oxidation reportedly increased by as much as 216%